About

About Cycle for Survival

Join the Battle.

The Cause

The Cause

"Learning that you have cancer—particularly an incurable cancer—is beyond scary. But every year Cycle for Survival gives me hope that new research will lead to better, more innovative treatments."

- Amy W.

Half of all patients are fighting a rare cancer.

About 50 percent of people with cancer have a rare cancer. Rare cancers include brain, pancreatic, ovarian, stomach, all types of pediatric cancers, and many others. Even though they account for about half of all cancer diagnoses when combined, research on many rare cancers is drastically underfunded, often leaving patients with limited or no treatment options. Memorial Sloan Kettering Cancer Center—the world’s oldest and largest private cancer center—is committed to changing that reality. MSK’s close collaboration between doctors and researchers is a unique strength: new drugs and therapies developed in the lab can be moved quickly to patients’ bedsides.

Quick Facts:

In 2018, roughly 1.7 million people will be diagnosed with cancer in the United States.

Approximately 50% of people with cancer are battling a rare cancer.

Rare cancers include brain, pancreatic, ovarian, thyroid, and stomach cancers; leukemia and lymphoma; all pediatric cancers; and many others.

Each year MSK treats more than 400 subtypes of cancer.

Every Dollar Fights Back

Every Dollar

"I ride because I know the difference clinical trials and research studies make—for our family the difference was one more year with our mother."

- Rachel B.

Cycle for Survival's indoor team cycling events raise funds that are critical for rare cancer research.

100% of every donation to Cycle for Survival is directly allocated to research at Memorial Sloan Kettering Cancer Center within six months of the events. The donations go to pioneering research and clinical trials, and have already led to new and better treatments for cancer patients worldwide. Memorial Sloan Kettering researchers collaborate with institutions around the world, and have led the way in developing new ways to diagnose and treat cancer. If you want to fight back against cancer, join us!

Quick Facts:

Cycle for Survival was founded in 2007.

100% of funds raised go directly to research at Memorial Sloan Kettering.

Rare cancers include brain, pancreatic, ovarian, thyroid, and stomach cancers; leukemia and lymphoma; all pediatric cancers; and many others.

Funds are allocated within six months of the events.

Direct Impact

Direct Impact

Thanks to the tremendous efforts of our participants, donors, and supporters, Cycle for Survival has raised $180 million for rare cancer research, and funded 100+ clinical trials and research studies.

The direct funding has drastically reduced the time it takes for treatments to reach patients—in some cases cutting the span from years to months. Doctors and researchers who have received Cycle for Survival funding credit these resources for making groundbreaking discoveries possible, advancing vital research where—typically—little to no funding exists.

Quick Facts:

$180 million has been raised by Cycle for Survival to date.

Cycle for Survival has directly contributed to 100+ clinical trials and research studies.

Download more information

2017 Funding Allocation PDF

Download  >

2016 Funding Allocation PDF

Download  >